Subscribe To
SRDX / Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio
SRDX News
By Zacks Investment Research
October 10, 2023
3 Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock. more_horizontal
By Zacks Investment Research
September 12, 2023
Surmodics (SRDX) Hits 52-Week High: What's Driving the Stock?
Investors are optimistic about Surmodics' (SRDX) consistent efforts to boost R&D. more_horizontal
By Business Wire
August 9, 2023
Surmodics to Participate in Upcoming Investor Conferences in August
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #Needham--SRDX, a provider of medical device and in vitro diagnostic technologies, announced management will pa more_horizontal
By Seeking Alpha
August 6, 2023
Surmodics, Inc. (SRDX) Q3 2023 Earnings Call Transcript
Surmodics, Inc. (NASDAQ:SRDX ) Q3 2023 Earnings Conference Call August 2, 2023 8:00 AM ET Company Participants Gary Maharaj - President & Chief Execut more_horizontal
By Zacks Investment Research
August 3, 2023
Surmodics (SRDX) Q3 Earnings Top Estimates, FY23 View Up
Surmodics (SRDX) reports a solid fiscal third quarter top line on the back of robust Medical Device revenues. more_horizontal
By Zacks Investment Research
August 2, 2023
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to comp more_horizontal
By Zacks Investment Research
August 2, 2023
SurModics (SRDX) Surpasses Q3 Earnings and Revenue Estimates
SurModics (SRDX) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of $0.46 per share. This compares more_horizontal
By Zacks Investment Research
June 28, 2023
Three Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock. more_horizontal